Literature DB >> 34524513

Comparison of interventions and outcomes of enhanced recovery after surgery: a systematic review and meta-analysis of 2456 adolescent idiopathic scoliosis cases.

Robert Koucheki1,2,3, Martin Koyle1,4, George M Ibrahim1,5, Jeremie Nallet3, David E Lebel6,7.   

Abstract

PURPOSE: The objective of this meta-analysis and systematic review is to compare the methodology and evaluate the efficacy of Enhanced recovery after Spine Surgery (ERAS) for adolescent idiopathic scoliosis (AIS) and to compare the outcomes with traditional discharge (TD) pathways.
METHODS: Using major databases, a systematic search was performed. Studies comparing the implementation of ERAS or ERAS-like and TD pathways in patients with AIS were identified. Data regarding methodology and outcomes were collected and analyzed.
RESULTS: Fourteen studies (n = 2456) were included, comprising 1081 TD and 1375 ERAS or ERAS-like patients. Average age of patients was 14.6 ± 0.4 years. Surgical duration was on average 35.6 min shorter for the ERAS group compared to TD cohort ([2.8, 68.3], p = 0.03), and blood loss was 112.3 milliliters less ([102.4, 122.2], p < 0.00001). ERAS group reached first ambulation 29.6 h earlier ([11.2, 48.0], p-0.002), patient-controlled-analgesia (PCA) discontinuation 0.53 day earlier ([0.4, 0.6], p < 0.00001), urinary catheter discontinuation 0.5 day earlier ([0.4, 0.6], p < 0.00001), and length-of-stay (LOS) was 1.6 days shorter ([1.4, 1.8], p < 0.00001). Rates of complications and 30-day-readmission-to-hospital were similar between both groups. Pain scores were significantly lower for ERAS group on days 0 through 2 post-operatively.
CONCLUSIONS: Use of ERAS after AIS is safe and effective, decreasing surgical duration and blood loss. ERAS methodology effectively focused on reducing time to first ambulation, PCA discontinuation, and urinary catheter removal. Outcomes showed significantly decreased LOS without a significant increase in complications. There should be efforts to incorporate ERAS in AIS surgery. Further studies are necessary to assess patient satisfaction. LEVEL OF EVIDENCE III: Meta-analysis of Level 3 studies.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Accelerated discharge; Adolescent idiopathic scoliosis; Enhanced recovery after surgery; Spine surgery

Mesh:

Year:  2021        PMID: 34524513     DOI: 10.1007/s00586-021-06984-0

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  34 in total

Review 1.  Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials.

Authors:  Massimiliano Greco; Giovanni Capretti; Luigi Beretta; Marco Gemma; Nicolò Pecorelli; Marco Braga
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

Review 2.  Meta-analysis of Enhanced Recovery After Surgery (ERAS) Protocols in Emergency Abdominal Surgery.

Authors:  Shahab Hajibandeh; Shahin Hajibandeh; Victor Bill; Thomas Satyadas
Journal:  World J Surg       Date:  2020-05       Impact factor: 3.352

3.  Blood loss estimation during posterior spinal fusion for adolescent idiopathic scoliosis.

Authors:  Nicholas D Fletcher; Laura E Gilbertson; Robert W Bruce; Matthew Lewis; Humphrey Lam; Thomas M Austin
Journal:  Spine Deform       Date:  2021-11-16

Review 4.  Enhanced Recovery After Surgery for Noncolorectal Surgery?: A Systematic Review and Meta-analysis of Major Abdominal Surgery.

Authors:  Anthony Visioni; Rupen Shah; Emmanuel Gabriel; Kristopher Attwood; Moshim Kukar; Steven Nurkin
Journal:  Ann Surg       Date:  2018-01       Impact factor: 12.969

5.  Use of a Novel Pathway for Early Discharge Was Associated With a 48% Shorter Length of Stay After Posterior Spinal Fusion for Adolescent Idiopathic Scoliosis.

Authors:  Nicholas D Fletcher; Lindsay M Andras; David E Lazarus; Robert J Owen; Benjamin J Geddes; Jessica Cao; David L Skaggs; Timothy S Oswald; Robert W Bruce
Journal:  J Pediatr Orthop       Date:  2017-03       Impact factor: 2.324

6.  An enhanced recovery after surgery program in orthopedic surgery: a systematic review and meta-analysis.

Authors:  Zhi-Chao Hu; Lin-Jie He; Dong Chen; Xiao-Bin Li; Zhen-Hua Feng; Cheng-Wei Fu; Jiang-Wei Xuan; Wen-Fei Ni; Ai-Min Wu
Journal:  J Orthop Surg Res       Date:  2019-03-13       Impact factor: 2.359

7.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.

Authors:  Matthew J Page; Joanne E McKenzie; Patrick M Bossuyt; Isabelle Boutron; Tammy C Hoffmann; Cynthia D Mulrow; Larissa Shamseer; Jennifer M Tetzlaff; Elie A Akl; Sue E Brennan; Roger Chou; Julie Glanville; Jeremy M Grimshaw; Asbjørn Hróbjartsson; Manoj M Lalu; Tianjing Li; Elizabeth W Loder; Evan Mayo-Wilson; Steve McDonald; Luke A McGuinness; Lesley A Stewart; James Thomas; Andrea C Tricco; Vivian A Welch; Penny Whiting; David Moher
Journal:  BMJ       Date:  2021-03-29

8.  An Optimized Enhanced Recovery After Surgery (ERAS) Pathway Improved Patient Care in Adolescent Idiopathic Scoliosis Surgery: A Retrospective Cohort Study.

Authors:  Yu-Jie Yang; Xin Huang; Xiao-Ning Gao; Bing Xia; Jian-Bo Gao; Chen Wang; Xiao-Ling Zhu; Xiao-Juan Shi; Hui-Ren Tao; Zhuo-Jing Luo; Jing-Hui Huang
Journal:  World Neurosurg       Date:  2020-10-12       Impact factor: 2.104

9.  Experience with an Enhanced Recovery After Spine Surgery protocol at an academic community hospital.

Authors:  Robert Young; Ethan Cottrill; Zach Pennington; Jeff Ehresman; A Karim Ahmed; Timothy Kim; Bowen Jiang; Daniel Lubelski; Alex M Zhu; Katherine S Wright; Donna Gavin; Alyson Russo; Marie N Hanna; Ali Bydon; Timothy F Witham; Corinna Zygourakis; Nicholas Theodore
Journal:  J Neurosurg Spine       Date:  2020-12-25

10.  Clinical and economic implications of early discharge following posterior spinal fusion for adolescent idiopathic scoliosis.

Authors:  Nicholas D Fletcher; Nader Shourbaji; Phillip M Mitchell; Timothy S Oswald; Dennis P Devito; Robert W Bruce
Journal:  J Child Orthop       Date:  2014-04-27       Impact factor: 1.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.